Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $79.7 million.

  • TransMedics' Total Current Liabilities rose 3276.21% to $79.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.7 million, marking a year-over-year increase of 3276.21%. This contributed to the annual value of $59.9 million for FY2024, which is 906.36% up from last year.
  • TransMedics' Total Current Liabilities amounted to $79.7 million in Q3 2025, which was up 3276.21% from $56.6 million recorded in Q2 2025.
  • TransMedics' 5-year Total Current Liabilities high stood at $79.7 million for Q3 2025, and its period low was $11.8 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $38.7 million, with a median of $32.0 million in 2023.
  • Per our database at Business Quant, TransMedics' Total Current Liabilities tumbled by 2182.33% in 2021 and then soared by 13732.9% in 2023.
  • Quarter analysis of 5 years shows TransMedics' Total Current Liabilities stood at $23.2 million in 2021, then rose by 1.82% to $23.7 million in 2022, then surged by 132.17% to $54.9 million in 2023, then rose by 9.06% to $59.9 million in 2024, then surged by 33.06% to $79.7 million in 2025.
  • Its last three reported values are $79.7 million in Q3 2025, $56.6 million for Q2 2025, and $55.6 million during Q1 2025.